Spondyloarthritis & psoriatic arthritis
Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness
Primary result · Rheumatology visits, mean numberResult — go to the resultMean difference −0.7 95% CI −1.0 to −0.3Authors' conclusion
PIFU and asynchronous telemedicine resulted in significant and clinically meaningful reductions in rheumatology visits. This was not at the expense of health outcomes and saved health-care costs.
Study context
- Population
- Patients with spondyloarthritis and stable disease (mean age 55.0 years; 40% women)ITT analysis
- Participants
- 200 patients
- Comparison
- Patient-initiated follow-up (PIFU) supported by asynchronous telemedicine vs usual care
- Primary endpoint
- Number of rheumatology visits within a 1-year period
- Follow-up
- 1 year
Methodological detailsmulticentre, pragmatic, open-label, 1:1 randomisation, trial-based 1-year health-economic evaluation, Individuals with relevant lived experience were involved in the study design
- Multicentre
- Pragmatic
- Open-label
- 1:1 randomisation
- Trial-based 1-year health-economic evaluation
- Individuals with relevant lived experience were involved in the study design
Primary result
Rheumatology visits, mean number
Mean difference
−0.7
95% CI −1.0 to −0.3
P < 0.0001
By group
PIFU and asynchronous telemedicine
1.9
mean · SD 1.5
Usual care
2.6
mean · SD 1.3
PIFU and asynchronous telemedicinevs Usual care
mean difference −0.7 (95% CI −1.0 to −0.3); P < 0.0001
As reported in the abstract
Further findings
| Outcome | Difference (€) (95% CI) | |
|---|---|---|
| Health-care costs (health-care perspective) · 1 yearPIFU and asynchronous telemedicinevs Usual care | −180 (−921 to 560) | |
| −1000−50005001000Difference, € (linear scale) |
| Outcome | Difference (95 % CI) | |
|---|---|---|
| Quality-adjusted life-years · 1 yearPIFU and asynchronous telemedicinevs Usual care | 0.004 (−0.022 to 0.030) | |
| −0.04−0.0200.020.04Difference (linear scale) |
Health-care costs (health-care perspective) · 1 year
- Cost-effective from a health-care perspective
Safety
Events
| Outcome | PIFU and asynchronous telemedicine | Usual care |
|---|---|---|
| Non-trial-related adverse eventsUsual care events include one death · intention-to-treat | 7 | 8 |
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness. Lancet Rheumatol. Published 1 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →